High tumor mutation burden predicts better efficacy of immunotherapy: a pooled analysis of 103078 cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High tumor mutation burden predicts better efficacy of immunotherapy: a pooled analysis of 103078 cancer patients

Published:2019-06-16 Issue:9 Volume:8 Page:e1629258
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Cao Dedong¹²,Xu Huilin³,Xu Ximing¹,Guo Tao⁴,Ge Wei¹

Affiliation:

1. Department of Oncology, RenMin Hospital of WuHan University, WuHan, Hubei, China

2. Department of Human biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

3. Department of Oncology, The Fifth Hospital of WuHan, WuHan, Hubei, China

4. Department of Hematology, The Union Hospital, Tongji Medical College, HuaZhong University of Science and Technology, WuHan, Hubei, China

Funder

National Natural Science Foundation of China

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2019.1629258

Reference59 articles.

1. Optimizing Cancer Treatment Using Game Theory

2. Genomics- and Transcriptomics-Based Patient Selection for Cancer Treatment With Immune Checkpoint Inhibitors

3. Tumor Mutation Burden: Leading Immunotherapy to the Era of Precision Medicine?

4. First FDA Approval Agnostic of Cancer Site — When a Biomarker Defines the Indication

5. Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploration of Key Genes Combining with Immune Infiltration Level and Tumor Mutational Burden in Hepatocellular Carcinoma;Combinatorial Chemistry & High Throughput Screening;2024-09

2. Tumour mutational burden: clinical utility, challenges and emerging improvements;Nature Reviews Clinical Oncology;2024-08-27

3. A novel M2-like tumor associated macrophages-related gene signature for predicting the prognosis and immunotherapy efficacy in gastric cancer;Discover Oncology;2024-08-16

4. A prognostic model constructed by ferroptosis-associated genes (FAGs) in papillary renal cell carcinoma (PRCC) and its association with tumor mutation burden (TMB) and immune infiltration;Clinical and Translational Oncology;2024-08-16

5. Immune- and metabolism-related gene signature analysis uncovers the prognostic and immune microenvironments of hepatocellular carcinoma;Journal of Cancer Research and Clinical Oncology;2024-06-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3